| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.04B | -9.4% |
| Cost of Revenue | $2.49B | -8.8% |
| R&D Expense | $4.0M | -33.3% |
| SG&A Expense | $412.0M | -9.5% |
| Interest Expense | $48.0M | -36.0% |
| Pre-tax Income | -$160.0M | -131.7% |
| Income Tax | $10.0M | -87.2% |
| Net Income | -$170.0M | -139.9% |
| EPS (Basic) | -$1.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $233.0M | -36.3% |
| Accounts Receivable | $500.0M | +1.4% |
| Current Assets | $1.07B | -14.6% |
| Total Assets | $2.40B | -7.8% |
| Current Liabilities | $681.0M | -8.5% |
| Long-term Debt | $665.0M | +8.1% |
| Total Liabilities | $1.57B | -2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.0M | -46.0% |
| Capital Expenditures | $59.0M | +110.7% |
| Investing Cash Flow | -$28.0M | -103.5% |
| Financing Cash Flow | -$39.0M | +95.6% |
| Free Cash Flow | -$132.0M | -69.2% |
| -150.0% |
| EPS (Diluted) | -$1.14 | -151.1% |
| Stockholders' Equity |
| $685.0M |
| -18.4% |